Figure 3.
Percentage of patients achieving a ≥50% reduction in low-density lipoprotein cholesterol and European Society of Cardiology–recommended low-density lipoprotein cholesterol targets with lerodalcibep compared with placebo during the study
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.